2008
DOI: 10.1016/j.bmcl.2008.03.073
|View full text |Cite
|
Sign up to set email alerts
|

Design and synthesis of tacrine–ferulic acid hybrids as multi-potent anti-Alzheimer drug candidates

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
126
0
4

Year Published

2011
2011
2020
2020

Publication Types

Select...
9

Relationship

4
5

Authors

Journals

citations
Cited by 175 publications
(133 citation statements)
references
References 24 publications
3
126
0
4
Order By: Relevance
“…With regard to the second path, tacrine derivatives 9 were prepared by reacting ethylenediamine or octane-1,8-diamine with 9-chlorotetrahydroacridine 8 using previously described procedures. 8,22 The synthesis of bivalent compounds (11a, b) with two tacrine moieties used a 1:2 ratio of DTE dicarboxylic acid and the tacrine derivative, whereas for the synthesis of univalent compounds (10a, b) a 1:1 ratio was applied (Scheme 1). In each case, two different spacer lengths were incorporated.…”
Section: ■ Results and Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…With regard to the second path, tacrine derivatives 9 were prepared by reacting ethylenediamine or octane-1,8-diamine with 9-chlorotetrahydroacridine 8 using previously described procedures. 8,22 The synthesis of bivalent compounds (11a, b) with two tacrine moieties used a 1:2 ratio of DTE dicarboxylic acid and the tacrine derivative, whereas for the synthesis of univalent compounds (10a, b) a 1:1 ratio was applied (Scheme 1). In each case, two different spacer lengths were incorporated.…”
Section: ■ Results and Discussionmentioning
confidence: 99%
“…Therefore, compound 11b in its ring-opened form represents a noncompetitive inhibitor of AChE. 8,25,26 In contrast, in its ringclosed form, a different Lineweaver−Burk curve illustrates the difference in K m and V max values. The K m values differ with different 11b concentrations, while the V max values remain essentially unchanged; that is, this photoisomer of 11b is a competitive inhibitor of AChE and therefore presumably might only inhibit the CAS of the enzyme.…”
Section: ■ Results and Discussionmentioning
confidence: 99%
“…Few of this class of inhibitors have yet been approved for AD therapy (Bachurin, 2003) and most of them have short half-life and peripheral cholinergic side effects (Fang et al, 2008;Mukherjee et al, 2007b;Nordberg & Svensson, 1998;Perry et al, 2003) which significantly limit its therapeutic use. Therefore, natural sources of compounds showing AChE inhibitory capacity must be sought.…”
Section: Research Articlementioning
confidence: 99%
“…Many compounds (e.g. galantamine and tacrine for Alzheimer's disease and acarbose for diabetes mellitus) are synthetically developed in drug industry, but they show adverse effects including gastrointestinal diseases and hepatotoxicity [7][8][9] . In this context, enzyme inhibitory properties of medicinal plants or plant-derived products are of great value in drug development era since their possible uses as natural enzyme inhibitors emerged from growing tendency to replace synthetic inhibitors by natural ones.…”
Section: Introductionmentioning
confidence: 99%